- Home
- BIO vs SKM Comparison
BIO vs SKM Comparison
Compare BIO & SKM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- SKM
- Stock Information
- Founded
- BIO 1952
- SKM 1984
- Country
- BIO United States
- SKM South Korea
- Employees
- BIO N/A
- SKM N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- SKM Telecommunications Equipment
- Sector
- BIO Industrials
- SKM Telecommunications
- Exchange
- BIO Nasdaq
- SKM Nasdaq
- Market Cap
- BIO 6.0B
- SKM N/A
- IPO Year
- BIO N/A
- SKM 1996
- Fundamental
- Price
- BIO $250.88
- SKM $22.13
- Analyst Decision
- BIO Strong Buy
- SKM Hold
- Analyst Count
- BIO 4
- SKM 1
- Target Price
- BIO $324.25
- SKM N/A
- AVG Volume (30 Days)
- BIO 397.8K
- SKM 543.1K
- Earning Date
- BIO 07-31-2025
- SKM 08-05-2025
- Dividend Yield
- BIO N/A
- SKM 3.85%
- EPS Growth
- BIO N/A
- SKM 10.48
- EPS
- BIO N/A
- SKM 3.95
- Revenue
- BIO $2,541,100,000.00
- SKM $12,191,932,706.00
- Revenue This Year
- BIO N/A
- SKM $1.65
- Revenue Next Year
- BIO $3.49
- SKM $1.59
- P/E Ratio
- BIO N/A
- SKM $10.08
- Revenue Growth
- BIO N/A
- SKM 1.21
- 52 Week Low
- BIO $211.43
- SKM $19.84
- 52 Week High
- BIO $387.99
- SKM $24.58
- Technical
- Relative Strength Index (RSI)
- BIO 62.71
- SKM 48.18
- Support Level
- BIO $245.87
- SKM $21.66
- Resistance Level
- BIO $255.13
- SKM $23.80
- Average True Range (ATR)
- BIO 6.95
- SKM 0.25
- MACD
- BIO 1.56
- SKM -0.14
- Stochastic Oscillator
- BIO 83.54
- SKM 21.73
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.